These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19121388)

  • 21. Pharmaceutical design of a novel colon-targeted delivery system using two-layer-coated tablets of three different pharmaceutical formulations, supported by clinical evidence in humans.
    Goto T; Tanida N; Yoshinaga T; Sato S; Ball DJ; Wilding IR; Kobayashi E; Fujimura A
    J Control Release; 2004 May; 97(1):31-42. PubMed ID: 15147802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examples of NIR based real time release in tablet manufacturing.
    Skibsted ET; Westerhuis JA; Smilde AK; Witte DT
    J Pharm Biomed Anal; 2007 Mar; 43(4):1297-305. PubMed ID: 17166686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of matrix controlled transdermal delivery systems of pentazocine: In vitro/in vivo performance.
    Prasad Verma PR; Chandak AR
    Acta Pharm; 2009 Jun; 59(2):171-86. PubMed ID: 19564142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin.
    Maroni A; Del Curto MD; Salmaso S; Zema L; Melocchi A; Caliceti P; Gazzaniga A
    Eur J Pharm Biopharm; 2016 Nov; 108():76-82. PubMed ID: 27519826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis and modeling of swelling and erosion behavior for pure HPMC tablet.
    Chirico S; Dalmoro A; Lamberti G; Russo G; Titomanlio G
    J Control Release; 2007 Sep; 122(2):181-8. PubMed ID: 17706830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New environmental sensitive system for colon-specific delivery of peptidic drugs.
    Luppi B; Bigucci F; Cerchiara T; Mandrioli R; Di Pietra AM; Zecchi V
    Int J Pharm; 2008 Jun; 358(1-2):44-9. PubMed ID: 18359586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
    Sinha VR; Mittal BR; Kumria R
    Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
    Hiremath PS; Saha RN
    Int J Pharm; 2008 Oct; 362(1-2):118-25. PubMed ID: 18640251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oral colon-targeting controlled release system based on resistant starch acetate: synthetization, characterization, and preparation of film-coating pellets.
    Pu H; Chen L; Li X; Xie F; Yu L; Li L
    J Agric Food Chem; 2011 May; 59(10):5738-45. PubMed ID: 21513356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device.
    Maggi L; Segale L; Conti S; Ochoa Machiste E; Salini A; Conte U
    Eur J Pharm Sci; 2005 Apr; 24(5):487-93. PubMed ID: 15784338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New spray congealing atomizer for the microencapsulation of highly concentrated solid and liquid substances.
    Albertini B; Passerini N; Pattarino F; Rodriguez L
    Eur J Pharm Biopharm; 2008 May; 69(1):348-57. PubMed ID: 17962005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro.
    Appel B; Maschke A; Weiser B; Sarhan H; Englert C; Angele P; Blunk T; Göpferich A
    Int J Pharm; 2006 May; 314(2):170-8. PubMed ID: 16569486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology).
    Sangalli ME; Maroni A; Busetti C; Zema L; Giordano F; Gazzaniga A
    Boll Chim Farm; 1999 Mar; 138(3):68-73. PubMed ID: 10394705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative estimation of the effects of bile salt surfactant systems on insulin stability and permeability in the rat intestine using a mass balance model.
    Lane ME; O'driscoll CM; Corrigan OI
    J Pharm Pharmacol; 2005 Feb; 57(2):169-75. PubMed ID: 15720779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.
    Calinescu C; Mateescu MA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):582-9. PubMed ID: 18602991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain.
    Koennings S; Sapin A; Blunk T; Menei P; Goepferich A
    J Control Release; 2007 Jun; 119(2):163-72. PubMed ID: 17428570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
    Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated conditions for stability assessment of bulk and formulated cefaclor monohydrate.
    Olsen BA; Perry FM; Snorek SV; Lewellen PL
    Pharm Dev Technol; 1997 Nov; 2(4):303-12. PubMed ID: 9552459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.